253 related articles for article (PubMed ID: 11445793)
21. Transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID.
Bordignon C; Mavilio F; Ferrari G; Servida P; Ugazio AG; Notarangelo LD; Gilboa E; Rossini S; O'Reilly RJ; Smith CA
Hum Gene Ther; 1993 Aug; 4(4):513-20. PubMed ID: 8399494
[TBL] [Abstract][Full Text] [Related]
22. [Gene therapy for adenosine deaminase deficiency].
Sakiyama Y; Ariga T; Ohtsu M
Nihon Rinsho; 2005 Mar; 63(3):448-52. PubMed ID: 15773344
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.
Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Brown BS; Paul ME; Abramson SL; Ritz J; Shearer WT
J Allergy Clin Immunol; 2008 Dec; 122(6):1185-93. PubMed ID: 19084111
[TBL] [Abstract][Full Text] [Related]
24. Suppression of an antibody to adenosine-deaminase (ADA) in an ADA-deficient patient receiving polyethylene glycol modified adenosine deaminase.
Chun JD; Lee N; Kobayashi RH; Chaffee S; Hershfield MS; Stiehm ER
Ann Allergy; 1993 Jun; 70(6):462-6. PubMed ID: 8507039
[TBL] [Abstract][Full Text] [Related]
25. Severe combined immunodeficiencies.
Fischer A
Immunodefic Rev; 1992; 3(2):83-100. PubMed ID: 1554500
[TBL] [Abstract][Full Text] [Related]
26. Severe combined immune deficiency in an adenosine deaminase-deficient patient.
Ozdemir O
Allergy Asthma Proc; 2006; 27(2):172-4. PubMed ID: 16724639
[TBL] [Abstract][Full Text] [Related]
27. PEG-ADA: an alternative to haploidentical bone marrow transplantation and an adjunct to gene therapy for adenosine deaminase deficiency.
Hershfield MS
Hum Mutat; 1995; 5(2):107-12. PubMed ID: 7749407
[TBL] [Abstract][Full Text] [Related]
28. Neonatal screening for severe combined immunodeficiency caused by an adenosine deaminase defect: a reliable and inexpensive method using tandem mass spectrometry.
Azzari C; la Marca G; Resti M
J Allergy Clin Immunol; 2011 Jun; 127(6):1394-9. PubMed ID: 21624616
[TBL] [Abstract][Full Text] [Related]
29. Generation of normal lymphocyte populations following transplantation of adenosine-deaminase-deficient fetal liver cells.
Migchielsen AA; Knaän-Schanzer S; Breuer ML; Hershfield MS; Valerio D
Bone Marrow Transplant; 1997 Jun; 19(11):1137-43. PubMed ID: 9193758
[TBL] [Abstract][Full Text] [Related]
30. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
Taupin P
IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313
[TBL] [Abstract][Full Text] [Related]
31. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P
Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640
[TBL] [Abstract][Full Text] [Related]
32. In vivo transduction by intravenous injection of a lentiviral vector expressing human ADA into neonatal ADA gene knockout mice: a novel form of enzyme replacement therapy for ADA deficiency.
Carbonaro DA; Jin X; Petersen D; Wang X; Dorey F; Kil KS; Aldrich M; Blackburn MR; Kellems RE; Kohn DB
Mol Ther; 2006 Jun; 13(6):1110-20. PubMed ID: 16651028
[TBL] [Abstract][Full Text] [Related]
33. Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency.
Ochs HD; Buckley RH; Kobayashi RH; Kobayashi AL; Sorensen RU; Douglas SD; Hamilton BL; Hershfield MS
Blood; 1992 Sep; 80(5):1163-71. PubMed ID: 1387561
[TBL] [Abstract][Full Text] [Related]
34. The inclusion of ADA-SCID in expanded newborn screening by tandem mass spectrometry.
la Marca G; Giocaliere E; Malvagia S; Funghini S; Ombrone D; Della Bona ML; Canessa C; Lippi F; Romano F; Guerrini R; Resti M; Azzari C
J Pharm Biomed Anal; 2014 Jan; 88():201-6. PubMed ID: 24076575
[TBL] [Abstract][Full Text] [Related]
35. Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency.
Sokolic R; Maric I; Kesserwan C; Garabedian E; Hanson IC; Dodds M; Buckley R; Issekutz AC; Kamani N; Shaw K; Tan B; Bali P; Hershfield MS; Kohn DB; Wayne AS; Candotti F
Blood; 2011 Sep; 118(10):2688-94. PubMed ID: 21725047
[TBL] [Abstract][Full Text] [Related]
36. Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation.
Blackburn MR; Kellems RE
Adv Immunol; 2005; 86():1-41. PubMed ID: 15705418
[TBL] [Abstract][Full Text] [Related]
37. Functional outcome at school age of preterm infants with periventricular hemorrhagic infarction.
Roze E; Van Braeckel KN; van der Veere CN; Maathuis CG; Martijn A; Bos AF
Pediatrics; 2009 Jun; 123(6):1493-500. PubMed ID: 19482759
[TBL] [Abstract][Full Text] [Related]
38. Long-Term Outcome of Adenosine Deaminase-Deficient Patients-a Single-Center Experience.
Scott O; Kim VH; Reid B; Pham-Huy A; Atkinson AR; Aiuti A; Grunebaum E
J Clin Immunol; 2017 Aug; 37(6):582-591. PubMed ID: 28748310
[TBL] [Abstract][Full Text] [Related]
39. A case of adenosine deaminase-negative severe combined immunodeficiency with neurological abnormalities.
Tezcan I; Ersoy F; Cağlar M; Sanal O; Kotiloğlu E; Aysun S
Turk J Pediatr; 1995; 37(4):383-9. PubMed ID: 8560606
[TBL] [Abstract][Full Text] [Related]
40. Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency.
Felgentreff K; Perez-Becker R; Speckmann C; Schwarz K; Kalwak K; Markelj G; Avcin T; Qasim W; Davies EG; Niehues T; Ehl S
Clin Immunol; 2011 Oct; 141(1):73-82. PubMed ID: 21664875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
